-
1
-
-
33845273878
-
High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up
-
Epub Nov 21
-
Villa LL, Costa RL, Petta CA & al, High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up. Br J Cancer, 2006; 95: 1459-66. (Epub 2006 Nov 21).
-
(2006)
Br J Cancer, 2006
, vol.95
, pp. 1459-1466
-
-
Villa, L.L.1
Costa, R.L.2
Petta, C.A.3
-
2
-
-
33748493750
-
Collins Y, Einstein MH, Gostout BS & al, Cervical cancer prevention in the era of prophylactic vaccines: A preview for gynecologic oncologists
-
Society of Gynecologic Oncologists Education Resource Panel Writing group;
-
Society of Gynecologic Oncologists Education Resource Panel Writing group; Collins Y, Einstein MH, Gostout BS & al, Cervical cancer prevention in the era of prophylactic vaccines: a preview for gynecologic oncologists. Gynecol Oncol, 2006; 102: 552-62.
-
(2006)
Gynecol Oncol
, vol.102
, pp. 552-562
-
-
-
3
-
-
33646058566
-
-
Harper DM, Franco EL, Wheeler CM & al, Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial. Lancet, 200615; 367: 1247-55.
-
Harper DM, Franco EL, Wheeler CM & al, Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial. Lancet, 200615; 367: 1247-55.
-
-
-
-
4
-
-
33845782389
-
Vaccination of healthy volunteers with human papillomavirus type 16 L2E7E6 fusion protein induces serum antibody that neutralizes across papillomavirus species
-
Gambhira R, Gravitt PE, Bossis I & al, Vaccination of healthy volunteers with human papillomavirus type 16 L2E7E6 fusion protein induces serum antibody that neutralizes across papillomavirus species. Cancer Res, 2006; 66: 11120-4.
-
(2006)
Cancer Res
, vol.66
, pp. 11120-11124
-
-
Gambhira, R.1
Gravitt, P.E.2
Bossis, I.3
-
5
-
-
33748744960
-
Prevention strategies of cervical cancer in the HPV vaccine era
-
Epub Aug 17
-
Bosch X & Harper D, Prevention strategies of cervical cancer in the HPV vaccine era. Gynecol Oncol, 2006; 103: 21-4 (Epub 2006 Aug 17).
-
(2006)
Gynecol Oncol, 2006
, vol.103
, pp. 21-24
-
-
Bosch, X.1
Harper, D.2
-
6
-
-
33845464643
-
The ethics and politics of compulsory HPV vaccination
-
Colgrove J, The ethics and politics of compulsory HPV vaccination. N Engl J Med, 2006; 355: 2389-91.
-
(2006)
N Engl J Med
, vol.355
, pp. 2389-2391
-
-
Colgrove, J.1
-
7
-
-
0033965659
-
The presence of HPV 16, 18 and p53 immunohistochemical staining in tumor tissue of Israeli Jewish women with cervical and vulvar neoplasia
-
Menczer J, Fintsi Y, Arbel-Alon S & al, The presence of HPV 16, 18 and p53 immunohistochemical staining in tumor tissue of Israeli Jewish women with cervical and vulvar neoplasia. Eur J Gynaecol Oncol, 2000; 21: 30-4.
-
(2000)
Eur J Gynaecol Oncol
, vol.21
, pp. 30-34
-
-
Menczer, J.1
Fintsi, Y.2
Arbel-Alon, S.3
-
8
-
-
0028436697
-
The inter-relationship of herpes virus, papilloma 16/18 virus infection and Pap smear pathology in Israeli women
-
Isacsohn M, Dolberg L, Sabag SG & al, The inter-relationship of herpes virus, papilloma 16/18 virus infection and Pap smear pathology in Israeli women. Isr J Med Sci, 1994; 30: 383-7.
-
(1994)
Isr J Med Sci
, vol.30
, pp. 383-387
-
-
Isacsohn, M.1
Dolberg, L.2
Sabag, S.G.3
|